EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.2.1.94 | Carcinoma |
8124665 |
Detoxification of cyclophosphamide by human aldehyde dehydrogenase isozymes. |
diagnostic usage ongoing research therapeutic application unassigned |
1 4 1 0 |
1.2.1.94 | Carcinoma, Hepatocellular |
7828219 |
Comparison of expression of aldehyde dehydrogenase 3 and CYP1A1 in dominant and recessive aryl hydrocarbon hydroxylase-deficient mutant mouse hepatoma cells. |
ongoing research unassigned |
3 0 |
1.2.1.94 | Carcinoma, Hepatocellular |
12604186 |
Aldehyde dehydrogenase 3 expression is decreased by clofibrate via PPAR gamma induction in JM2 rat hepatoma cell line. |
causal interaction ongoing research unassigned |
4 3 0 |
1.2.1.94 | Carcinoma, Hepatocellular |
12604187 |
Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |
1.2.1.94 | Carcinoma, Hepatocellular |
26118777 |
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. |
causal interaction diagnostic usage therapeutic application unassigned |
2 1 1 0 |
1.2.1.94 | Fanconi Anemia |
28007957 |
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair. |
unassigned |
0 |
1.2.1.94 | Leukemia |
26118777 |
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. |
causal interaction diagnostic usage therapeutic application unassigned |
2 1 1 0 |
1.2.1.94 | Neoplasms |
12604187 |
Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |
1.2.1.94 | Neoplasms |
19355878 |
Synergetic Bitherapy in Mice with Xenografts of Human Prostate Cancer Using a Methional Mimic (METLICO) and an Aldehyde Dehydrogenase 3 Inhibitor (MATE): Systemic Intraperitoneal (IP) and Targeted Intra-Tumoral (IT) Administration. |
ongoing research therapeutic application unassigned |
4 1 0 |
1.2.1.94 | Pancreatic Neoplasms |
28671577 |
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells. |
diagnostic usage ongoing research unassigned |
1 2 0 |